Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Adaptive Biotechnologies
ADPT
$3.68B
| $1.79M | ﹤0.01% |
202,429
-396,135
| -66% | -$3.49M |
|
2227
Tidewater
TDW
$3.73B
| $1.79M | ﹤0.01% |
40,546
+20,158
| +99% | +$866K |
|
2228
OSI Systems
OSIS
$3.72B
| $1.78M | ﹤0.01% |
17,404
-1,543
| -8% | -$143K |
|
2229
O-I Glass
OI
$1.14B
| $1.78M | ﹤0.01% |
78,392
+3,224
| +4% | +$67.7K |
|
2230
Axalta
AXTA
$7.76B
| $1.77M | ﹤0.01% |
58,505
+5,968
| +11% | +$171K |
|
|
BLUE
2231
DELISTED
bluebird bio
BLUE
| $1.77M | ﹤0.01% |
27,854
-725
| -3% | -$82.8K |
|
2232
McGrath RentCorp
MGRC
$2.92B
| $1.77M | ﹤0.01% |
18,985
+3,086
| +19% | +$305K |
|
2233
Progyny
PGNY
$2.47B
| $1.77M | ﹤0.01% |
55,026
+18,288
| +50% | +$604K |
|
2234
Prestige Consumer Healthcare
PBH
$2.46B
| $1.77M | ﹤0.01% |
28,189
-4,175
| -13% | -$261K |
|
2235
Federal Agricultural Mortgage
AGM
$2.58B
| $1.76M | ﹤0.01% |
13,250
-13,246
| -50% | -$1.74M |
|
2236
Werner Enterprises
WERN
$2.24B
| $1.76M | ﹤0.01% |
38,735
+8,311
| +27% | +$377K |
|
|
SFIX
2237
Stitch Fix
SFIX
$536M
| $1.76M | ﹤0.01% |
344,067
+52,545
| +18% | +$246K |
|
2238
Crinetics Pharmaceuticals
CRNX
$8.89B
| $1.75M | ﹤0.01% |
109,273
+40,430
| +59% | +$748K |
|
|
CGC
2239
PUT
Canopy Growth
CGC
$404M
| $1.75M | ﹤0.01% |
+100,000
| New | +$2.37M |
|
2240
Nelnet
NNI
$4.97B
| $1.75M | ﹤0.01% |
19,031
+681
| +4% | +$63.1K |
|
2241
Kiniksa Pharmaceuticals
KNSA
$5.73B
| $1.75M | ﹤0.01% |
162,179
+102,172
| +170% | +$1.35M |
|
|
SASR
2242
DELISTED
Sandy Spring Bancorp Inc
SASR
| $1.74M | ﹤0.01% |
67,122
+6,670
| +11% | +$215K |
|
2243
Unifirst Corp
UNF
$5.3B
| $1.74M | ﹤0.01% |
9,880
+505
| +5% | +$98.5K |
|
2244
Addus HomeCare
ADUS
$2.18B
| $1.74M | ﹤0.01% |
16,292
+433
| +3% | +$45.2K |
|
2245
Graham Holdings Company
GHC
$5.14B
| $1.74M | ﹤0.01% |
2,917
+1,345
| +86% | +$836K |
|
|
PPLI
2246
People Inc
PPLI
$3.09B
| $1.74M | ﹤0.01% |
41,045
+2,166
| +6% | +$92.7K |
|
2247
United States Natural Gas Fund
UNG
$473M
| $1.74M | ﹤0.01% |
+62,534
| New | +$2.27M |
|
2248
Compass Minerals
CMP
$1.21B
| $1.74M | ﹤0.01% |
50,600
+869
| +2% | +$34.7K |
|
2249
American States Water
AWR
$3.32B
| $1.73M | ﹤0.01% |
19,463
+1,598
| +9% | +$146K |
|
2250
Triumph Financial Inc
TFIN
$1.81B
| $1.72M | ﹤0.01% |
29,625
+7,908
| +36% | +$453K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.